| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Armata Pharmaceuticals, Inc. | Director | Stock Options (Right to Buy) | 94,009 | 14 Mar 2024 | Direct | ||
| Armata Pharmaceuticals, Inc. | Director | Stock Options (Right to Buy) | 54,343 | 05 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARMP | Armata Pharmaceuticals, Inc. | 05 Feb 2025 | 1 | $0 | 4 | Director | 07 Feb 2025, 16:20 |
| ARMP | Armata Pharmaceuticals, Inc. | 14 Mar 2024 | 2 | $0 | 4 | Director | 18 Mar 2024, 20:03 |
| ARMP | Armata Pharmaceuticals, Inc. | 21 Dec 2023 | 1 | $0 | 4 | Director | 26 Dec 2023, 21:55 |
| ARMP | Armata Pharmaceuticals, Inc. | 13 Apr 2022 | 1 | $0 | 4 | Director | 15 Apr 2022, 15:56 |
| ARMP | Armata Pharmaceuticals, Inc. | 07 Jun 2021 | 1 | $0 | 4 | Director | 09 Jun 2021, 16:26 |